Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Express Diagnostics Int'l announces start of operations at new subsidiary in Bulgaria

Express Diagnostics Int'l, Inc., FDA-registered and ISO 13485:2003-certified medical device manufacturer, announces Express Diagnostics Global, Ltd., a new subsidiary based in Sofia, Bulgaria is operational.

30 Jul 2016

Bukert Life Science uses Twin Power design to produce microfluidic valves in three sizes

Bukert Life Science releases Microfluidic valves with Twin Power technology, now available in three sizes - 10mm, 16mm, and 22mm.

30 Jul 2016

New LPD Series dispense pump meets demands of modern day applications

After 20 years of experience designing and manufacturing dispense pumps for in vitro diagnostics and scientific instrument applications, The Lee Company is pleased to offer its most cost effective design yet.

30 Jul 2016

Delta Modtech to showcase transdermal converting and coating machine at AACC

Delta ModTech offers innovative solutions for manufacturing a variety of complex medical, pharmaceutical, label, security, RFID, packaging and cosmetic products.

30 Jul 2016

Web Industries announces opening of new LFI production facility

Web Industries, Inc., innovative provider of precision contract manufacturing and converting services, is proud to announce the opening of the company's first lateral flow immunoassay (LFI) production facility.

30 Jul 2016

Researchers develop new approach to manufacturing mechanical metamaterials

Ill-fitting joint sockets, contact dermatitis and sebaceous cysts are just a few of the problems plaguing prosthetic patients. They are all a result of the pressure that their prosthetic devices place on the soft tissue of their bodies.

29 Jul 2016

Scientists identify mutation responsible for new, rare genetic disorder

An international team of researchers has discovered the mutation responsible for a rare, newly identified genetic disorder that causes craniofacial abnormalities and developmental delays.

28 Jul 2016

New FSG article explains key terms linked to bioinks and bioprinting

Future Science Group today announced the publication of a new article in Future Science OA looking to identify and define key terms associated with bioinks and bioprinting.

25 Jul 2016

Scientists develop simple method for building complex reconfigurable microrobots

For the past few years, scientists around the world have been studying ways to use miniature robots to better treat a variety of diseases.

22 Jul 2016

New study offers hypothesis why obese patients fare worse during cancer treatment

Across many cancer types, obese patients fare worse than leaner patients. Now a University of Colorado Cancer Center study published in the journal Cell Stem Cell offers a compelling hypothesis why: researchers found that leukemia stem cells "hide" in fatty tissue, even transforming this tissue in ways that support their survival when challenged with chemotherapy. It is as if leukemia stem cells not only use fatty tissue as a robbers' cave to hide from therapy, but actively adapt this cave to their liking.

21 Jul 2016

New technique could help produce enhanced imaging results with ordinary microscopes

Research completed through a collaboration with University of Missouri engineers, biologists, and chemists could transform how scientists study molecules and cells at sub-microscopic (nanoscale) levels.

20 Jul 2016

Cambridge Consultants creates new Evonetix spin-out to focus on accurate DNA synthesis

A breakthrough in DNA synthesis has led to the creation of a new spin-out company from the stable of product design and development firm Cambridge Consultants.

19 Jul 2016

CSIRO's partner Oventus Medical listed on ASX after raising $12 million

CSIRO partner Oventus Medical Ltd has today listed on the Australian Securities Exchange raising $12m.

19 Jul 2016

Increasing access to MRI scanning: an interview with Jane Kilkenny

MRI scanners use strong magnetic fields, radio waves and field gradients to produce cross sectional images throughout the human body.

12 Jul 2016

MD Anderson, ILC Dover and NASA partner to increase awareness of childhood cancer

Today, several of Space City's best-known institutions -- The University of Texas MD Anderson Cancer Center, the National Aeronautics and Space Administration and ILC Dover -- announced a partnership that brings the benefits of arts and science to pediatric cancer patients while increasing awareness of childhood cancer.

11 Jul 2016

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

Sandoz, a Novartis division, and the pioneer and global leader in biosimilars, today announced results from the EGALITY trial in which the primary endpoint of achieving equivalence in Psoriasis Area and Severity Index (PASI) 75 response rates at week 12 was met.

8 Jul 2016

World’s most intelligent prosthetic limb? An interview with Professor Saeed Zahedi

The main challenges for lower limb amputees are safety and pain. Lack of sensory feedback leading to an increased risk of falling, compensatory movements due to instability causing lower back pain and discomfort between the residual limb and prosthesis all contribute to a significant reduction in confidence and an inability to live a full life.

7 Jul 2016

WRAIR collaborates with Sanofi Pasteur to develop ZPIV vaccine candidate

The Walter Reed Army Institute of Research announces a Cooperative Research and Development Agreement for the development of a Zika vaccine candidate with Sanofi Pasteur, the vaccines division of Sanofi.

7 Jul 2016

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.

6 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

Manufacturing News and Research

Further Reading

Express Diagnostics Int'l announces start of operations at new subsidiary in Bulgaria

Bukert Life Science uses Twin Power design to produce microfluidic valves in three sizes

New LPD Series dispense pump meets demands of modern day applications

Delta Modtech to showcase transdermal converting and coating machine at AACC

Web Industries announces opening of new LFI production facility

Researchers develop new approach to manufacturing mechanical metamaterials

Scientists identify mutation responsible for new, rare genetic disorder

New FSG article explains key terms linked to bioinks and bioprinting

Scientists develop simple method for building complex reconfigurable microrobots

New study offers hypothesis why obese patients fare worse during cancer treatment

New technique could help produce enhanced imaging results with ordinary microscopes

Cambridge Consultants creates new Evonetix spin-out to focus on accurate DNA synthesis

CSIRO's partner Oventus Medical listed on ASX after raising $12 million

Increasing access to MRI scanning: an interview with Jane Kilkenny

MD Anderson, ILC Dover and NASA partner to increase awareness of childhood cancer

New data shows Sandoz biosimilar etanercept candidate has equivalent efficacy to originator product

World’s most intelligent prosthetic limb? An interview with Professor Saeed Zahedi

WRAIR collaborates with Sanofi Pasteur to develop ZPIV vaccine candidate

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®